A detailed history of Brevan Howard Capital Management LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 21,597 shares of JAZZ stock, worth $2.66 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,597
Previous 13,874 55.67%
Holding current value
$2.66 Million
Previous $1.48 Million 62.64%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $776,702 - $898,725
7,723 Added 55.67%
21,597 $2.41 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $1.02 Million - $1.16 Million
9,768 Added 237.9%
13,874 $1.48 Million
Q1 2024

May 15, 2024

SELL
$115.19 - $132.77 $973,355 - $1.12 Million
-8,450 Reduced 67.3%
4,106 $494,000
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $1.43 Million - $1.71 Million
12,556 New
12,556 $1.54 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.